Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790]
- PMID: 32173085
- DOI: 10.1016/j.biopha.2020.110077
Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790]
Erratum for
-
IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway.Biomed Pharmacother. 2020 Mar;123:109790. doi: 10.1016/j.biopha.2019.109790. Epub 2019 Dec 30. Biomed Pharmacother. 2020. PMID: 31896065
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
